CollabRx Featured on NBC News (VIDEO)
06 août 2013 06h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 6, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, was featured on an NBC Bay...
CollabRx Featured in Forbes Article: "Can We Build A Kickstarter For Cancer?"
05 août 2013 09h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, was featured a Forbes...
CollabRx, Inc. Schedules First Quarter Fiscal Year 2014 Financial Conference Call and Business Update
31 juil. 2013 09h05 HE
|
CollabRx, Inc.
SAN FRANCISCO, July 31, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on August 13,...
CollabRx to Present at the 2013 Southern California Investor Conference
30 juil. 2013 09h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, July 30, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R....
CollabRx Retains Hayden IR to Develop Strategic Investor Relations Program
25 juil. 2013 16h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, July 25, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announced it has engaged...
CollabRx to Collaborate With the University of Chicago Medical Center on Clinical Cancer Sequencing and Interpretation
18 juin 2013 09h21 HE
|
CollabRx, Inc.
SAN FRANCISCO, June 18, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a...
CollabRx Reports Fourth Quarter and Fiscal Year 2013 Financial Results
03 juin 2013 16h00 HE
|
CollabRx, Inc.
SAN FRANCISCO, Calif., June 3, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the fourth quarter and for the full Fiscal Year 2013, which...
CollabRx Schedules Q4 and Full Fiscal Year 2013 Financial Conference Call and Business Update
21 mai 2013 15h32 HE
|
CollabRx, Inc.
SAN FRANCISCO, May 21, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on June 3,...
CollabRx and GeneInsight to Collaborate on Interpretation and Reporting Service for Clinical Genetic Sequencing
08 mai 2013 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO and BOSTON, May 8, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing the clinical interpretation of molecular diagnostic testing, and...
CollabRx Partners With Sengenics for Molecular Diagnostics
09 avr. 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, April 9, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), today announced a partnership with Sengenics, a leading genetic diagnostics company, to provide turn-key diagnostic...